Why insider trading matters?

If management teams do not own any relevant stakes in the companies they guide, they may not be focused on creating wealth for shareholders to the same degree, compared to those that see their personal wealth increase when share prices rise.

- Klaus Gugler, Economist
CYTOKINETICS INC (CYTK)
Sector: Healthcare; Industry: Biotechnology

Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company is developing small molecule drug candidates primarily engineered to increase muscle function and contractility. Its drug candidates include omecamtiv mecarbil, a novel cardiac myosin activator that is in Phase III clinical trial in patients with heart failure; and reldesemtiv, a novel fast skeletal muscle troponin activator, which is in Phase II clinical trial to treat amyotrophic lateral sclerosis and spinal muscular atrophy.


Trade Date Insider Title Buy/Sell #Shares Price Value Option
2021-04-15 SMITH SANDFORD D Director Sell 10,714 $25.23 $270,350 Yes
2021-04-12 Blum Robert I President & CEO Sell 5,000 $23.56 $117,813 Yes
2021-04-09 SMITH SANDFORD D Director Sell 27,582 $23.93 $659,990 Yes
2021-04-08 Malik Fady Ibraham EVP Research & Development Sell 2,000 $23.39 $46,772 No
2021-04-01 HENDERSON JOHN T Director Sell 3,333 $23.54 $78,474 Yes
2021-03-22 Blum Robert I President & CEO Sell 5,000 $25.19 $125,972 Yes
2021-03-19 GAGE L PATRICK Director Sell 10,000 $24.45 $244,468 Yes
2021-03-12 GAGE L PATRICK Director Sell 10,339 $21.22 $219,372 Yes
2021-03-11 Malik Fady Ibraham EVP Research & Development Sell 2,000 $19.90 $39,798 No
2021-03-08 Blum Robert I President & CEO Sell 5,000 $19.49 $97,472 Yes
2021-02-26 Blum Robert I President & CEO Sell 5,000 $19.33 $96,650 Yes
2021-02-11 Malik Fady Ibraham EVP Research & Development Sell 1,632 $23.34 $38,097 No
2021-02-10 Blum Robert I President & CEO Sell 5,000 $23.88 $119,384 Yes
2021-01-29 Blum Robert I President & CEO Sell 5,000 $20.34 $101,701 Yes
2021-01-20 Blum Robert I President & CEO Sell 5,000 $20.41 $102,042 Yes
2021-01-14 Malik Fady Ibraham EVP Research & Development Sell 12,500 $19.25 $240,619 Yes
2021-01-04 Blum Robert I President & CEO Sell 5,000 $20.23 $101,135 Yes
2020-12-31 HENDERSON JOHN T Director Sell 858 $20.31 $17,426 Yes
2020-12-16 Blum Robert I President & CEO Sell 5,000 $20.51 $102,551 Yes
2020-12-15 GAGE L PATRICK Director Sell 7,716 $21.00 $162,038 Yes
2020-12-09 BVF PARTNERS L P/IL nan Sell 430,954 $18.00 $7,757,172 No
2020-12-10 Malik Fady Ibraham EVP Research & Development Sell 1,052 $20.13 $21,177 No
2020-12-04 Blum Robert I President & CEO Sell 5,000 $17.36 $86,798 Yes
2020-11-23 Blum Robert I President & CEO Sell 5,000 $15.73 $78,644 Yes
2020-11-12 Malik Fady Ibraham EVP Research & Development Sell 1,231 $17.15 $21,112 No
2020-11-10 Blum Robert I President & CEO Sell 5,000 $16.50 $82,488 Yes
2020-10-29 Blum Robert I President & CEO Sell 5,000 $15.15 $75,773 Yes
2020-10-13 Blum Robert I President & CEO Sell 5,000 $15.94 $79,686 Yes
2020-10-08 Malik Fady Ibraham EVP Research & Development Sell 1,258 $17.45 $21,952 No
2020-10-05 PARSHALL B LYNNE Director Sell 50,311 $30.00 $1,509,330 Yes

Insider Smart

MGM Resorts International (MGM) - If we were to pick one of the easy trade from the crash, it has to be MGM, checkout the impressive insider buying after crash. Do you really need more confidence to pull the trigger? That's the mental edge you need to work against fear.